DGX vs. CRL
Compare and contrast key facts about Quest Diagnostics Incorporated (DGX) and Charles River Laboratories International, Inc. (CRL).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: DGX or CRL.
Correlation
The correlation between DGX and CRL is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
DGX vs. CRL - Performance Comparison
Key characteristics
DGX:
0.79
CRL:
-0.53
DGX:
1.36
CRL:
-0.60
DGX:
1.16
CRL:
0.93
DGX:
0.65
CRL:
-0.32
DGX:
3.01
CRL:
-0.94
DGX:
5.34%
CRL:
21.10%
DGX:
20.26%
CRL:
37.01%
DGX:
-49.46%
CRL:
-69.81%
DGX:
-6.58%
CRL:
-59.47%
Fundamentals
DGX:
$17.36B
CRL:
$9.68B
DGX:
$7.43
CRL:
$8.00
DGX:
20.93
CRL:
23.67
DGX:
1.81
CRL:
2.44
DGX:
$9.54B
CRL:
$4.06B
DGX:
$3.08B
CRL:
$1.37B
DGX:
$1.78B
CRL:
$990.36M
Returns By Period
In the year-to-date period, DGX achieves a 13.43% return, which is significantly higher than CRL's -21.42% return. Over the past 10 years, DGX has underperformed CRL with an annualized return of 10.74%, while CRL has yielded a comparatively higher 11.40% annualized return.
DGX
13.43%
-5.10%
11.32%
14.96%
9.73%
10.74%
CRL
-21.42%
-1.13%
-12.21%
-21.19%
4.15%
11.40%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
DGX vs. CRL - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Quest Diagnostics Incorporated (DGX) and Charles River Laboratories International, Inc. (CRL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
DGX vs. CRL - Dividend Comparison
DGX's dividend yield for the trailing twelve months is around 1.93%, while CRL has not paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DGX Quest Diagnostics Incorporated | 1.93% | 2.02% | 2.08% | 1.40% | 1.85% | 1.99% | 2.34% | 1.83% | 1.72% | 2.07% | 1.92% | 2.24% |
CRL Charles River Laboratories International, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
DGX vs. CRL - Drawdown Comparison
The maximum DGX drawdown since its inception was -49.46%, smaller than the maximum CRL drawdown of -69.81%. Use the drawdown chart below to compare losses from any high point for DGX and CRL. For additional features, visit the drawdowns tool.
Volatility
DGX vs. CRL - Volatility Comparison
The current volatility for Quest Diagnostics Incorporated (DGX) is 5.04%, while Charles River Laboratories International, Inc. (CRL) has a volatility of 9.99%. This indicates that DGX experiences smaller price fluctuations and is considered to be less risky than CRL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
DGX vs. CRL - Financials Comparison
This section allows you to compare key financial metrics between Quest Diagnostics Incorporated and Charles River Laboratories International, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities